HUP0400255A2 - Retinoid receptor ligandumok és kiválasztott citotoxikus szerek szinergikus kombinációi rák kezelésére - Google Patents
Retinoid receptor ligandumok és kiválasztott citotoxikus szerek szinergikus kombinációi rák kezelésére Download PDFInfo
- Publication number
- HUP0400255A2 HUP0400255A2 HU0400255A HUP0400255A HUP0400255A2 HU P0400255 A2 HUP0400255 A2 HU P0400255A2 HU 0400255 A HU0400255 A HU 0400255A HU P0400255 A HUP0400255 A HU P0400255A HU P0400255 A2 HUP0400255 A2 HU P0400255A2
- Authority
- HU
- Hungary
- Prior art keywords
- retinoic acid
- acid receptor
- cytotoxic agent
- selected cytotoxic
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27775401P | 2001-03-22 | 2001-03-22 | |
| PCT/US2002/008718 WO2002078620A2 (en) | 2001-03-22 | 2002-03-22 | Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0400255A2 true HUP0400255A2 (hu) | 2004-08-30 |
Family
ID=23062213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0400255A HUP0400255A2 (hu) | 2001-03-22 | 2002-03-22 | Retinoid receptor ligandumok és kiválasztott citotoxikus szerek szinergikus kombinációi rák kezelésére |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1383491A2 (https=) |
| JP (1) | JP2004528316A (https=) |
| KR (1) | KR20030086314A (https=) |
| CN (1) | CN1498105A (https=) |
| BR (1) | BR0207681A (https=) |
| CA (1) | CA2441335A1 (https=) |
| CZ (1) | CZ20032540A3 (https=) |
| DE (1) | DE02733871T1 (https=) |
| ES (1) | ES2214985T1 (https=) |
| HU (1) | HUP0400255A2 (https=) |
| IL (1) | IL157358A0 (https=) |
| MX (1) | MXPA03008403A (https=) |
| PL (1) | PL368946A1 (https=) |
| TR (1) | TR200400812T3 (https=) |
| WO (1) | WO2002078620A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5113038B2 (ja) * | 2006-03-23 | 2013-01-09 | テムリック株式会社 | 癌治療用キットおよび癌治療用医薬組成物 |
-
2002
- 2002-03-22 WO PCT/US2002/008718 patent/WO2002078620A2/en not_active Ceased
- 2002-03-22 TR TR2004/00812T patent/TR200400812T3/xx unknown
- 2002-03-22 CA CA002441335A patent/CA2441335A1/en not_active Abandoned
- 2002-03-22 IL IL15735802A patent/IL157358A0/xx unknown
- 2002-03-22 DE DE0001383491T patent/DE02733871T1/de active Pending
- 2002-03-22 JP JP2002576888A patent/JP2004528316A/ja not_active Withdrawn
- 2002-03-22 PL PL02368946A patent/PL368946A1/xx not_active Application Discontinuation
- 2002-03-22 HU HU0400255A patent/HUP0400255A2/hu unknown
- 2002-03-22 ES ES02733871T patent/ES2214985T1/es active Pending
- 2002-03-22 BR BR0207681-0A patent/BR0207681A/pt not_active Application Discontinuation
- 2002-03-22 MX MXPA03008403A patent/MXPA03008403A/es unknown
- 2002-03-22 CN CNA028070011A patent/CN1498105A/zh active Pending
- 2002-03-22 KR KR10-2003-7012217A patent/KR20030086314A/ko not_active Withdrawn
- 2002-03-22 EP EP02733871A patent/EP1383491A2/en not_active Withdrawn
- 2002-03-22 CZ CZ20032540A patent/CZ20032540A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1498105A (zh) | 2004-05-19 |
| PL368946A1 (pl) | 2005-04-04 |
| IL157358A0 (en) | 2004-02-19 |
| BR0207681A (pt) | 2004-07-27 |
| KR20030086314A (ko) | 2003-11-07 |
| DE02733871T1 (de) | 2004-08-26 |
| TR200400812T3 (tr) | 2004-07-21 |
| ES2214985T1 (es) | 2004-10-01 |
| JP2004528316A (ja) | 2004-09-16 |
| WO2002078620A2 (en) | 2002-10-10 |
| CA2441335A1 (en) | 2002-10-10 |
| CZ20032540A3 (cs) | 2004-05-12 |
| WO2002078620A3 (en) | 2003-04-17 |
| MXPA03008403A (es) | 2004-01-29 |
| EP1383491A2 (en) | 2004-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bertram et al. | Cancer prevention by retinoids and carotenoids: independent action on a common target | |
| Leeman et al. | STAT3 as a therapeutic target in head and neck cancer | |
| Zusi et al. | Selective retinoids and rexinoids in cancer therapy and chemoprevention | |
| WO2008144475A1 (en) | Methods and compositions for treating cancer | |
| US11358933B2 (en) | Compounds and methods for inhibiting CYP26 enzymes | |
| JP2014076953A (ja) | レチノイドｘ受容体パーシャルアゴニスト化合物及びこのレチノイドｘ受容体パーシャルアゴニスト化合物を有効成分として含有する薬剤 | |
| Huang et al. | Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells | |
| Lo et al. | Effects of all-trans retinoic acid, retinol, and β-carotene on murine macrophage activity | |
| AU701790B2 (en) | Method for treating cancers using 6-{3-{1-adamantyl}- 4-hydroxyphenyl} | |
| JP4737931B2 (ja) | 医薬品の製造におけるヒドロキシオレイン酸及び類似化合物の使用 | |
| Vitoux et al. | Acute promyelocytic leukemia: new issues on pathogenesis and treatment response | |
| Garcia-Bates et al. | Role of peroxisome proliferator‐activated receptor gamma and its ligands in the treatment of hematological malignancies | |
| Thompson et al. | 1, 25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53 | |
| Wozniak et al. | Parthenolide complements the cell death-inducing activity of doxorubicin in melanoma cells | |
| JP5885140B2 (ja) | Ｒｘｒパーシャルアゴニスト | |
| Das et al. | Anti-cancer potential of all-trans retinoic acid (ATRA): a review | |
| US20040122080A1 (en) | Synergist combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer | |
| HUP0400255A2 (hu) | Retinoid receptor ligandumok és kiválasztott citotoxikus szerek szinergikus kombinációi rák kezelésére | |
| Wallace et al. | RRD-251 enhances all-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells | |
| WO2012014936A1 (ja) | 癌幹細胞の分化誘導剤 | |
| Marchwicka et al. | Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review | |
| US6211239B1 (en) | Method for treating or preventing breast cancer or leukemia using 6-[3-[1-adamantyl]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN) | |
| AU2002305072A1 (en) | Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer | |
| US20070259829A1 (en) | Uses of diphenyl/diphenylamine carboxylic acids | |
| Weber | Drugs that Suppress Proliferation |